Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antipsychotics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 First Generation
  • 1.3.3 Second Generation
  • 1.3.4 Third Generation
• 1.4 Market Segment by Application
  • 1.4.1 Global Antipsychotics Market Share by Application (2019-2025)
  • 1.4.2 Schizophrenia
  • 1.4.3 Bipolar Disorder
  • 1.4.4 Unipolar Depression
  • 1.4.5 Dementia
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antipsychotics Market Size
  • 2.1.1 Global Antipsychotics Revenue 2014-2025
  • 2.1.2 Global Antipsychotics Sales 2014-2025
• 2.2 Antipsychotics Growth Rate by Regions
  • 2.2.1 Global Antipsychotics Sales by Regions 2014-2019
  • 2.2.2 Global Antipsychotics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antipsychotics Sales by Manufacturers
  • 3.1.1 Antipsychotics Sales by Manufacturers 2014-2019
  • 3.1.2 Antipsychotics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antipsychotics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antipsychotics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antipsychotics Market Concentration Ratio (CR5 and HHI)
• 3.3 Antipsychotics Price by Manufacturers
• 3.4 Key Manufacturers Antipsychotics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antipsychotics Market
• 3.6 Key Manufacturers Antipsychotics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 First Generation Sales and Revenue (2014-2019)
  • 4.1.2 Second Generation Sales and Revenue (2014-2019)
  • 4.1.3 Third Generation Sales and Revenue (2014-2019)
• 4.2 Global Antipsychotics Sales Market Share by Type
• 4.3 Global Antipsychotics Revenue Market Share by Type
• 4.4 Antipsychotics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antipsychotics Sales by Application

6 United States

• 6.1 United States Antipsychotics Breakdown Data by Company
• 6.2 United States Antipsychotics Breakdown Data by Type
• 6.3 United States Antipsychotics Breakdown Data by Application

7 European Union

• 7.1 European Union Antipsychotics Breakdown Data by Company
• 7.2 European Union Antipsychotics Breakdown Data by Type
• 7.3 European Union Antipsychotics Breakdown Data by Application

8 China

• 8.1 China Antipsychotics Breakdown Data by Company
• 8.2 China Antipsychotics Breakdown Data by Type
• 8.3 China Antipsychotics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antipsychotics Breakdown Data by Company
• 9.2 Rest of World Antipsychotics Breakdown Data by Type
• 9.3 Rest of World Antipsychotics Breakdown Data by Application
• 9.4 Rest of World Antipsychotics Breakdown Data by Countries
  • 9.4.1 Rest of World Antipsychotics Sales by Countries
  • 9.4.2 Rest of World Antipsychotics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Johnson & Johnson
  • 10.1.1 Johnson & Johnson Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.1.4 Antipsychotics Product Introduction
  • 10.1.5 Johnson & Johnson Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.2.4 Antipsychotics Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Eli Lilly & Co
  • 10.3.1 Eli Lilly & Co Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.3.4 Antipsychotics Product Introduction
  • 10.3.5 Eli Lilly & Co Recent Development
• 10.4 Bristol-Myers Squibb
  • 10.4.1 Bristol-Myers Squibb Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.4.4 Antipsychotics Product Introduction
  • 10.4.5 Bristol-Myers Squibb Recent Development
• 10.5 AstraZeneca
  • 10.5.1 AstraZeneca Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.5.4 Antipsychotics Product Introduction
  • 10.5.5 AstraZeneca Recent Development
• 10.6 Glaxo SmithKline
  • 10.6.1 Glaxo SmithKline Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.6.4 Antipsychotics Product Introduction
  • 10.6.5 Glaxo SmithKline Recent Development
• 10.7 Allergan
  • 10.7.1 Allergan Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antipsychotics
  • 10.7.4 Antipsychotics Product Introduction
  • 10.7.5 Allergan Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antipsychotics Sales Channels
  • 11.2.2 Antipsychotics Distributors
• 11.3 Antipsychotics Customers

12 Market Forecast

• 12.1 Global Antipsychotics Sales and Revenue Forecast 2019-2025
• 12.2 Global Antipsychotics Sales Forecast by Type
• 12.3 Global Antipsychotics Sales Forecast by Application
• 12.4 Antipsychotics Forecast by Regions
  • 12.4.1 Global Antipsychotics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antipsychotics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
In 2019, the market size of Antipsychotics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antipsychotics.

This report studies the global market size of Antipsychotics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antipsychotics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Johnson & Johnson
Pfizer
Eli Lilly & Co
Bristol-Myers Squibb
AstraZeneca
Glaxo SmithKline
Allergan
...

Market Segment by Product Type
First Generation
Second Generation
Third Generation

Market Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antipsychotics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antipsychotics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antipsychotics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025